Pfam Domains GO Terms
| negative regulation of germinal center formation |
| T follicular helper cell differentiation |
| negative regulation of T-helper 17 cell differentiation |
| regulation of germinal center formation |
| negative regulation of T-helper 17 type immune response |
| regulation of miRNA metabolic process |
| negative regulation of activated T cell proliferation |
| cytoplasmic mRNA processing body assembly |
| negative regulation of T-helper cell differentiation |
| negative regulation of B cell proliferation |
| 3-UTR-mediated mRNA destabilization |
| lymph node development |
| regulation of T-helper 17 cell differentiation |
| regulation of T-helper 17 type immune response |
| negative regulation of CD4-positive, alpha-beta T cell differentiation |
| RNA stem-loop binding |
| negative regulation of alpha-beta T cell differentiation |
| B cell homeostasis |
| CD4-positive, alpha-beta T cell differentiation involved in immune response |
| T-helper cell differentiation |
| alpha-beta T cell activation involved in immune response |
| alpha-beta T cell differentiation involved in immune response |
| negative regulation of CD4-positive, alpha-beta T cell activation |
| mRNA destabilization |
| miRNA binding |
| negative regulation of B cell activation |
| RNA destabilization |
| T cell differentiation involved in immune response |
| spleen development |
| T cell homeostasis |
| regulation of T-helper cell differentiation |
| CD4-positive, alpha-beta T cell differentiation |
| regulation of activated T cell proliferation |
| negative regulation of alpha-beta T cell activation |
| T cell proliferation |
| regulation of T cell receptor signaling pathway |
| CD4-positive, alpha-beta T cell activation |
| negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| negative regulation of T cell differentiation |
| negative regulation of adaptive immune response |
| regulation of CD4-positive, alpha-beta T cell differentiation |
| positive regulation of mRNA catabolic process |
| alpha-beta T cell differentiation |
| negative regulation of lymphocyte differentiation |
| lymphocyte homeostasis |
| nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
| negative regulation of T cell proliferation |
| regulation of CD4-positive, alpha-beta T cell activation |
| regulation of B cell proliferation |
| alpha-beta T cell activation |
| regulation of alpha-beta T cell differentiation |
| regulation of antigen receptor-mediated signaling pathway |
| T cell activation involved in immune response |
| cytoplasmic stress granule |
| leukocyte homeostasis |
| double-stranded RNA binding |
| negative regulation of lymphocyte proliferation |
| negative regulation of mononuclear cell proliferation |
| mRNA 3-UTR binding |
| positive regulation of NIK/NF-kappaB signaling |
| positive regulation of mRNA metabolic process |
| negative regulation of leukocyte proliferation |
| lymphocyte proliferation |
| P-body |
| mononuclear cell proliferation |
| regulation of alpha-beta T cell activation |
| leukocyte proliferation |
| negative regulation of leukocyte differentiation |
| regulation of NIK/NF-kappaB signaling |
| negative regulation of T cell activation |
| lymphocyte activation involved in immune response |
| negative regulation of immune effector process |
| negative regulation of leukocyte cell-cell adhesion |
| negative regulation of translation |
| T cell differentiation |
| negative regulation of hemopoiesis |
| regulation of T cell differentiation |
| negative regulation of lymphocyte activation |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| negative regulation of cellular amide metabolic process |
| negative regulation of immune response |
| regulation of T cell proliferation |
| regulation of adaptive immune response |
| regulation of lymphocyte differentiation |
| cellular response to interleukin-1 |
| negative regulation of cell-cell adhesion |
| negative regulation of leukocyte activation |
| T cell receptor signaling pathway |
| regulation of mRNA stability |
| regulation of RNA stability |
| negative regulation of cell activation |
| nuclear-transcribed mRNA catabolic process |
| response to interleukin-1 |
| homeostasis of number of cells |
| regulation of mRNA catabolic process |
| regulation of B cell activation |
| regulation of lymphocyte proliferation |
| regulation of mononuclear cell proliferation |
| mRNA catabolic process |
| ubiquitin protein ligase activity |
| regulation of leukocyte proliferation |
| ribonucleoprotein complex assembly |
| T cell activation |
| lymphocyte differentiation |
| ribonucleoprotein complex subunit organization |
| ubiquitin-protein transferase activity |
| RNA catabolic process |
| negative regulation of cell adhesion |
| regulation of leukocyte differentiation |
| antigen receptor-mediated signaling pathway |
| regulation of leukocyte cell-cell adhesion |
| protein polyubiquitination |
| regulation of T cell activation |
| regulation of mRNA metabolic process |
| leukocyte differentiation |
| regulation of translation |
| positive regulation of cellular catabolic process |
| nucleobase-containing compound catabolic process |
| lymphocyte activation |
| regulation of cell-cell adhesion |
| regulation of cellular amide metabolic process |
| positive regulation of catabolic process |
| heterocycle catabolic process |
| cellular nitrogen compound catabolic process |
| negative regulation of immune system process |
| aromatic compound catabolic process |
| immune response-activating cell surface receptor signaling pathway |
| regulation of hemopoiesis |
| ribonucleoprotein complex biogenesis |
| regulation of immune effector process |
| organic cyclic compound catabolic process |
| immune response-regulating cell surface receptor signaling pathway |
| regulation of lymphocyte activation |
| posttranscriptional regulation of gene expression |
| cell population proliferation |
| hemopoiesis |
| immune response-activating signal transduction |
| immune response-regulating signaling pathway |
| regulation of leukocyte activation |
| hematopoietic or lymphoid organ development |
| leukocyte activation involved in immune response |
| cell activation involved in immune response |
| activation of immune response |
| regulation of cell activation |
| immune system development |
| negative regulation of cell population proliferation |
| regulation of cell adhesion |
| protein ubiquitination |
| mRNA metabolic process |
| negative regulation of cell differentiation |
| organelle assembly |
| protein modification by small protein conjugation |
| regulation of cellular catabolic process |
| zinc ion binding |
| cellular protein-containing complex assembly |
| positive regulation of immune response |
| cellular macromolecule catabolic process |
| leukocyte activation |
| negative regulation of developmental process |
| protein modification by small protein conjugation or removal |
| regulation of catabolic process |
| cellular response to cytokine stimulus |
| positive regulation of intracellular signal transduction |
| negative regulation of cellular protein metabolic process |
| macromolecule catabolic process |
| regulation of anatomical structure morphogenesis |
| cell activation |
| immune effector process |
| response to cytokine |
| negative regulation of protein metabolic process |
| positive regulation of immune system process |
| regulation of immune response |
| negative regulation of multicellular organismal process |
| negative regulation of cellular macromolecule biosynthetic process |
| RNA binding |
| negative regulation of macromolecule biosynthetic process |
| negative regulation of cellular biosynthetic process |
| negative regulation of biosynthetic process |
| protein-containing complex assembly |
| regulation of cell population proliferation |
| negative regulation of response to stimulus |
| homeostatic process |
| regulation of immune system process |
| positive regulation of signal transduction |
| RNA metabolic process |
| negative regulation of gene expression |
| positive regulation of RNA metabolic process |
| organic substance catabolic process |
| cellular catabolic process |
| regulation of cell differentiation |
| positive regulation of cell communication |
| positive regulation of signaling |
| regulation of intracellular signal transduction |
| protein-containing complex subunit organization |
| immune response |
| positive regulation of nucleobase-containing compound metabolic process |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Screen | Score |
|---|---|
| BML-284 0.09μM R08 exp460 | -2.68 |
| Nutlin-3A 1.6μM R06 exp294 | -2.19 |
| Azithromycin 100μM R08 exp452 | -2.13 |
| IWR1 50μM R08 exp495 | -2.07 |
| Vinblastine 0.002μM R01 exp60 | -2.07 |
| HMS-I1 1μM R01 exp46 | -1.97 |
| Taxol 0.002μM R01 exp54 | -1.85 |
| Mdivi-1 15μM R05 exp217 | -1.82 |
| Chloroquine 32μM R08 exp470 | -1.71 |
| Docetaxel 0.002μM R01 exp45 | -1.7 |
| LY2090314 0.003μM R08 exp499 | 2.4 |
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Expression Distribution